Tian X, Yang Q, Wu J. Effect of Apatinib Mesylate on Clinical Remission Rate and Adverse Reactions in Patients with Advanced Primary Hepatocellular Carcinoma. IJBLS [Internet]. 2024 Feb. 22 [cited 2026 Jun. 27];5(1):13-6. Available from: https://drpress.org/ojs/index.php/ijbls/article/view/16556